Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Multiple Myeloma 70 Leukemia, Myeloid, Acute 70 Lymphoma, Large B-Cell, Diffuse 61 Lymphoma, Non-Hodgkin 58 Leukemia, Lymphocytic, Chronic, B-Cell 57 Lymphoma 56 Melanoma 52 Leukemia 52 Breast Neoplasms 49 Burkitt Lymphoma 48 Myelodysplastic Syndromes 44 Recurrence 41 Lymphoma, Follicular 41 Lymphoma, B-Cell 38 Lymphoma, Mantle-Cell 37 Neuroblastoma 32 Ovarian Neoplasms 31 Lymphoma, B-Cell, Marginal Zone 27 Sarcoma 26 Neoplasms 26 Carcinoma, Non-Small-Cell Lung 25 Hodgkin Disease 24 Neoplasm Metastasis 23 Triple Negative Breast Neoplasms 18 Carcinoma, Renal Cell 18 Neoplasms, Plasma Cell 17 Hematologic Neoplasms 17 Leukemia, Myelomonocytic, Chronic 16 Colorectal Neoplasms 16

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Neoplasm × Cyclophosphamide × Clear all

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡